• Arya B Mohabbat, Bradley R Salonen, Xiomari D Davis, Mary M Volcheck, Connie A Luedtke, Lasonya T Natividad, Tito D Pena Guzman, Shirley M Johnson, Abigail J Ledvina, Cozette Thatcher L Merza, and Elizabeth C Wight.
• Mayo Clinic, Division of General Internal Medicine, Rochester, MN. Electronic address: mohabbat.arya@mayo.edu.
• Pain Manag Nurs. 2024 Aug 1; 25 (4): 389394389-394.

PurposePatient education is a core component of treating fibromyalgia and central sensitization disorders. We sought to evaluate whether patients with fibromyalgia prefer virtual or in-person educational classes as part of their treatment program, identify underlying factors with their educational modality choice, and highlight benefits or barriers associated with in-person or online educational sessions.DesignA cross-sectional survey with a qualitative feedback component was utilized.MethodsA voluntary, anonymous survey was distributed to all participants (in-person and virtual) of the fibromyalgia and chronic fatigue clinic treatment program from October 2021 through March 2022.ResultsIn total 90 participants completed the survey. Nearly all (94%) agreed that the pathophysiologic education was relevant and valuable and (98%) agreed to feeling confident with implementing management strategies. Perceived connection between the participants varied between groups (85% of in-person vs 48% of online; p < .001), as did perceived engagement (100% of in-person vs 71% of online; p = .001).ConclusionsPatients value education and find it useful in treating fibromyalgia, regardless of the educational modality. The online group reported more limitations including less engagement, class participation, and connection with peers.Clinical ImplicationsAs virtual education platforms become more widely available and may be easier to access than in-person options, it is important to understand patient preferences, benefits, and disadvantages of educational modalities to ensure education and patient outcomes remain equitable.Copyright © 2024. Published by Elsevier Inc.

29 keywords...

hide…